PLCG1 mutations in cutaneous T-cell lymphomas

 c-Signaling Cytokines Induce a Regulatory T Cell Phenotype in Malignant CD4+ T Lymphocytes

(2014) M. Kasprzycka et al.   JOURNAL OF IMMUNOLOGY

RUbioSeq: a suite of parallelized pipelines to automate exome variation and bisulfite-seq analyses

(2013) M. Rubio-Camarillo et al.   BIOINFORMATICS

Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma

(2012) F. Cedeno-Laurent et al.   BLOOD

The tumour suppressor p53 is frequently nonfunctional in Sézary syndrome

(2012) B. Lamprecht et al.   BRITISH JOURNAL OF DERMATOLOGY

The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma

(2012) Ronnie M. Abraham et al.   CANCER BIOLOGY & THERAPY

Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells

(2012) D.-K. Chang et al.   MOLECULAR CANCER THERAPEUTICS

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

(2012) Roland Schmitz et al.   NATURE

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

(2012) Li Ding et al.   NATURE

New Mutations in Chronic Lymphocytic Leukemia Identified by Target Enrichment and Deep Sequencing

(2012) Elena Doménech et al.   PLoS One

High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade

(2011) M. K. Kiessling et al.   BLOOD

Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)

(2011) Henry K. Wong et al.   BRITISH JOURNAL OF HAEMATOLOGY

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

(2011) Elise A. Olsen et al.   JOURNAL OF CLINICAL ONCOLOGY

Malignant Cutaneous T-Cell Lymphoma Cells Express IL-17 Utilizing the Jak3/Stat3 Signaling Pathway

(2011) Thorbjørn Krejsgaard et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Characterization of the DNA Copy-Number Genome in the Blood of Cutaneous T-Cell Lymphoma Patients

(2011) William M. Lin et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome

(2011) T Krejsgaard et al.   LEUKEMIA

Genetic alterations in Sezary syndrome

(2011) Katarzyna Iżykowska et al.   LEUKEMIA & LYMPHOMA

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

(2011) Xose S. Puente et al.   NATURE

Analysis of the coding genome of diffuse large B-cell lymphoma

(2011) Laura Pasqualucci et al.   NATURE GENETICS

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

(2011) Víctor Quesada et al.   NATURE GENETICS

SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts

(2011) E. Papaemmanuil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Synergistic and combinatorial control of T cell activation and differentiation by transcription factors

(2010) Mark S Sundrud et al.   CURRENT OPINION IN IMMUNOLOGY

Receptor signaling in immune cell development and function

(2010) Xiao-Ping Zhong et al.   IMMUNOLOGIC RESEARCH

Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal

(2010) Nita Sally Agar et al.   JOURNAL OF CLINICAL ONCOLOGY

Oncogenically active MYD88 mutations in human lymphoma

(2010) Vu N. Ngo et al.   NATURE

Generation of pathogenic TH17 cells in the absence of TGF-β signalling

(2010) Kamran Ghoreschi et al.   NATURE

Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases

(2009) P. T. Bradford et al.   BLOOD

Identification of Key Regions and Genes Important in the Pathogenesis of Sezary Syndrome by Combining Genomic and Expression Microarrays

(2009) E. Caprini et al.   CANCER RESEARCH

Cutaneous T-Cell Lymphoma: Roles for Chemokines and Chemokine Receptors

(2009) Xue-Song Wu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Oligonucleotide Array-CGH Identifies Genomic Subgroups and Prognostic Markers for Tumor Stage Mycosis Fungoides

(2009) Rocío Salgado et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Differential CCR4 Expression And Function in Cutaneous T-Cell Lymphoma Cell Lines

(2009) Chieh-Shan Wu et al.   KAOHSIUNG JOURNAL OF MEDICAL SCIENCES

Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome

(2009) Elaine R. Mardis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel and Highly Recurrent Chromosomal Alterations in Sezary Syndrome

(2008) M. H. Vermeer et al.   CANCER RESEARCH

Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma

(2008) V. R. Fantin et al.   CANCER RESEARCH

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

(2008) Timothy J. Ley et al.   NATURE